FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) from Verity Pharmaceuticals Inc., authorizing an updated indication or labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Precocious Puberty
• Endometriosis
• Prostate Cancer
• Uterine Fibroids

Drugs mentioned

• TRELSTAR (Triporelin pamoate)

Snippet

SUPPL AP for TRELSTAR (TRIPTORELIN PAMOATE)